Enzymotec Ltd. to Participate in the Jefferies 2015 Global Healthcare Conference

MIGDAL HA'EMEQ, Israel, May 20, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that Dr. Ariel Katz, President and Chief Executive Officer, will present at the Jefferies 2015 Global Healthcare Conference on Tuesday, June 2, 2015 at 1:30 p.m. ET at the Grand Hyatt in New York City.

The conference presentation will be broadcast over the Internet as a "live" listen only webcast. To listen, please go to Investors section of the Company's website at www.enzymotec.com. An archive of the event will also be available for those unable to listen live.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit www.enzymotec.com.

CONTACT: KCSA Strategic Communications Jeffrey Goldberger / Tram Bui 212.896.1249 / 212.896.1290 ENZY@kcsa.com

Source:Enzymotec Ltd.